The U.S. Food and Drug Administration has approved the first drug in the U.S. that includes a sensor inside pills that can detect whether a patient has taken them.
The drug, Abilify MyCite, is approved for the treatment of schizophrenia, manic episodes associated with bipolar disorder and as an add-on treatment for depression in adults.
Abilify MyCite was developed by Otsuka Pharmaceutical Co. Ltd. and Proteus Digital Health. The system works by sending a signal from the pill’s sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can ...
Comments